S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
80
Participants
Timeline
Start Date
January 31, 2015
Primary Completion Date
June 30, 2021
Study Completion Date
December 31, 2021
Conditions
Pancreatic Cancer
Interventions
DRUG
S-1, Gemcitabine
Trial Locations (1)
310006
First affiliated hospital, Zhejiang University, Hangzhou
All Listed Sponsors
lead
Zhejiang University
OTHER
NCT02131493 - S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer | Biotech Hunter | Biotech Hunter